Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joris R Julsing"'
The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2.
Autor:
Dzjemma Sarkisjan, Joris R Julsing, Kees Smid, Daniël de Klerk, André B P van Kuilenburg, Rutger Meinsma, Young B Lee, Deog J Kim, Godefridus J Peters
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162901 (2016)
Fluorocyclopentenylcytosine (RX-3117) is an orally available cytidine analog, currently in Phase I clinical trial. RX-3117 has promising antitumor activity in various human tumor xenografts including gemcitabine resistant tumors. RX-3117 is activated
Externí odkaz:
https://doaj.org/article/ecd36541f4fd43e4b410765524e870bd
Autor:
Larry H. Matherly, Young Bok Lee, Joris R. Julsing, Dzjemma Sarkisjan, Btissame El Hassouni, Godefridus J. Peters, Deog Joong Kim, Ietje Kathmann, Richard J. Honeywell
Publikováno v:
Sarkisjan, D, Julsing, J R, El Hassouni, B, Honeywell, R J, Kathmann, I, Matherly, L H, Lee, Y B, Kim, D J & Peters, G J 2020, ' Rx-3117 (Fluorocyclopentenyl-cytosine)-mediated down-regulation of dna methyltransferase 1 leads to protein expression of tumor-suppressor genes and increased functionality of the proton-coupled folate carrier ', International Journal of Molecular Sciences, vol. 21, no. 8, 2717 . https://doi.org/10.3390/ijms21082717
International Journal of Molecular Sciences
Volume 21
Issue 8
International Journal of Molecular Sciences, 21(8):2717. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, Vol 21, Iss 2717, p 2717 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 8
International Journal of Molecular Sciences, 21(8):2717. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, Vol 21, Iss 2717, p 2717 (2020)
(1) Background: RX-3117 (fluorocyclopentenyl-cytosine) is a cytidine analog that inhibits DNA methyltransferase 1 (DNMT1). We investigated the mechanism and potential of RX-3117 as a demethylating agent in several in vitro models. (2) Methods: we use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a0b844558a3fc411cacfcb3190c8d10
https://research.vumc.nl/en/publications/038cd18b-dcaa-4848-94b5-1a8098b9efcb
https://research.vumc.nl/en/publications/038cd18b-dcaa-4848-94b5-1a8098b9efcb
Autor:
Elisa Giovannetti, Young Bok Lee, Godefridus J. Peters, Daniel J. De Klerk, Dzjemma Sarkisjan, Kees Smid, Deog Joong Kim, Btissame El Hassouni, Joris R. Julsing, Safet Zekanovic, Richard J. Honeywell, Beatrice Balboni
Publikováno v:
Cancer Research. 79:1267-1267
RX-3117 is a novel cytidine analog showing encouraging results in ongoing Phase 2a studies with gemcitabine-resistant pancreatic ductal adenocarcinoma and advanced urothelial bladder cancer. Cellular uptake of RX-3117 is mediated by the equilibrative
Autor:
Rutger Meinsma, Young Bok Lee, Joris R. Julsing, Dzjemma Sarkisjan, Daniel de Klerk, Kees Smid, Deog Joong Kim, Godefridus J. Peters, André B.P. van Kuilenburg
Publikováno v:
PLoS ONE, 11(9). Public Library of Science
Sarkisjan, D, Julsing, J R, Smid, K, de Klerk, D, van Kuilenburg, A B P, Meinsma, R, Lee, Y B, Kim, D J & Peters, G J 2016, ' The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2 ', PLoS ONE, vol. 11, no. 9 . https://doi.org/10.1371/journal.pone.0162901
PLoS ONE
PLoS ONE, Vol 11, Iss 9, p e0162901 (2016)
Sarkisjan, D, Julsing, J R, Smid, K, de Klerk, D, van Kuilenburg, A B P, Meinsma, R, Lee, Y B, Kim, D J & Peters, G J 2016, ' The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2 ', PLoS ONE, vol. 11, no. 9 . https://doi.org/10.1371/journal.pone.0162901
PLoS ONE
PLoS ONE, Vol 11, Iss 9, p e0162901 (2016)
Fluorocyclopentenylcytosine (RX-3117) is an orally available cytidine analog, currently in Phase I clinical trial. RX-3117 has promising antitumor activity in various human tumor xenografts including gemcitabine resistant tumors. RX-3117 is activated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89172426006ecc70eba60f075b608615
https://research.vumc.nl/en/publications/b5036ec3-8627-4d40-8e05-b3cf3247d794
https://research.vumc.nl/en/publications/b5036ec3-8627-4d40-8e05-b3cf3247d794
Autor:
Gregoire Maroteaux, Joris R. Julsing, Oliver Stiedl, Rick van Vliet, Paula du Pont, Torben Hager
Publikováno v:
Hager, T, Maroteaux, G P, Pont, P D, Julsing, J, van Vliet, R & Stiedl, O 2014, ' Munc18-1 haploinsufficiency results in enhanced anxiety-like behavior as determined by heart rate responses in mice ', Behavioural Brain Research, vol. 260, pp. 44-52 . https://doi.org/10.1016/j.bbr.2013.11.033
Behavioural Brain Research, 260, 44-52. Elsevier
Behavioural Brain Research, 260, 44-52. Elsevier
Heterozygous (HZ) missense mutations in the gene encoding syntaxin binding protein 1 (Stxbp1 or Munc18-1), a presynaptic protein essential for neurotransmitter release, causes early infantile epileptic encephalopathy, abnormal brain structure and men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d023f5e77ad04ae9a853538b56a4f6c
https://research.vu.nl/en/publications/24d1ba57-8194-4c44-880f-f622e9caec70
https://research.vu.nl/en/publications/24d1ba57-8194-4c44-880f-f622e9caec70
Autor:
Mi Y. Yang, Dzjemma Sarkisjan, Daniel de Klerk, Kees Smid, Godefridus J. Peters, Young Bok Lee, Joris R. Julsing, Deog Joong Kim
Publikováno v:
Cancer Research. 75:2622-2622
Fluorocyclopentenylcytosine (RX-3117) is an orally bioavailable novel cytidine analog, currently being tested in a Phase I clinical trial. RX-3117 shows promising antitumor activity in various human tumor xenografts including patient derived xenograf